Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Perspective Therapeutics, Inc. | 50,000 | reported | 02 Mar 2026 | tx 56+5,012,160−811,538 |
Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 8 buys in history.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Mar 2026 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 31 Mar 2025 | PURCHASE | Perspective Therapeutics, Inc. | 23,475 | 2.13 USD | |
| 03 Mar 2025 | GRANT_AWARD | Perspective Therapeutics, Inc. | 50,000 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Perspective Therapeutics, Inc. | 23,000 | 0.00 USD | deriv |
| 14 Jun 2024 | PURCHASE | Perspective Therapeutics, Inc. | 4,504 | 10.90 USD | |
| 14 Jun 2024 | PURCHASE | Perspective Therapeutics, Inc. | 83 | 10.80 USD | |
| 03 Jun 2024 | PURCHASE | Perspective Therapeutics, Inc. | 34,246 | 1.46 USD | |
| 15 Dec 2023 | PURCHASE | Perspective Therapeutics, Inc. | 152,962 | 0.27 USD | |
| 14 Dec 2023 | PURCHASE | Perspective Therapeutics, Inc. | 32,238 | 0.27 USD | first after silence |
| 12 Dec 2023 | GRANT_AWARD | Perspective Therapeutics, Inc. | 230,000 | 0.00 USD | deriv |
| 13 Apr 2023 | EXERCISE | Perspective Therapeutics, Inc. | 163,934 | 0.61 USD | |
| 17 Apr 2023 | EXERCISE | Perspective Therapeutics, Inc. | 23,566 | 0.61 USD | |
| 17 Apr 2023 | EXERCISE | Perspective Therapeutics, Inc. | 23,566 | 0.00 USD | deriv |
| 13 Apr 2023 | EXERCISE | Perspective Therapeutics, Inc. | 163,934 | 0.00 USD | deriv |
| 21 Feb 2023 | GRANT_AWARD | Perspective Therapeutics, Inc. | 230,000 | 0.00 USD | deriv |
| 21 Feb 2023 | GRANT_AWARD | Perspective Therapeutics, Inc. | 470,000 | 0.00 USD | deriv |
| 15 Nov 2022 | PURCHASE | Perspective Therapeutics, Inc. | 100,000 | 0.34 USD | |
| 21 Jul 2022 | GRANT_AWARD | Perspective Therapeutics, Inc. | 940,000 | 0.00 USD | deriv |
| 07 Jun 2022 | PURCHASE | Perspective Therapeutics, Inc. | 75,000 | 0.30 USD | first after silence |
| 23 Nov 2021 | EXERCISE | Perspective Therapeutics, Inc. | 62,500 | 0.46 USD | |
| 23 Nov 2021 | EXERCISE | Perspective Therapeutics, Inc. | 62,500 | 0.43 USD | |
| 23 Nov 2021 | EXERCISE | Perspective Therapeutics, Inc. | 62,500 | 0.00 USD | deriv |
| 23 Nov 2021 | EXERCISE | Perspective Therapeutics, Inc. | 62,500 | 0.00 USD | deriv |
| 01 Jul 2021 | GRANT_AWARD | Perspective Therapeutics, Inc. | 480,000 | 0.00 USD | deriv |
| 12 Mar 2021 | EXERCISE | Perspective Therapeutics, Inc. | 24,038 | 0.57 USD |
3 purchases reported after at least 12 months of silence — most recent on 14 Dec 2023.